The paramyxovirus Newcastle disease virus (NDV) contains two glycoproteins, one required for virus-cell fusion [the fusion (F) glycoprotein], the other for virus-cell adsorption [the haemagglutinin-neuraminidase (HN) glycoprotein] (Choppin & Scheid, 1980) . Monoclonal antibodies (MAbs) against either glycoprotein can neutralize the virus and be used to select MAb-resistant mutants Iorio & Bratt, 1985; Samson et al., 1985; Meulemans et al., 1986) .
Monoclonal antibodies can be used to identify separate antigenic sites within a protein and epitopes within a given site using a variety of techniques such as competition antibody binding and cross-reaction of antibody-resistant mutants and virus strains Iorio et al., 1986; Iorio & Bratt, 1984; Nishikawa et al., 1983 Nishikawa et al., , 1986 . The positions of epitopes with a given protein sequence can be determined from genome sequence analysis of antibody-resistant mutants, a technique pioneered with influenza virus (Wiley et al., 1981) and now being used with some paramyxoviruses (Portner et al., 1987; Coelingh et al., 1986) .
A total of nine MAbs was used in this study each of which react with the H N protein of NDV. MAbs 8C11,4D6, AC3, JB6, 2B6 and 8E8 have been described elsewhere . MAbs 14 and 445 were kindly provided by Dr P. H. Russell (Royal Veterinary College, London, U.K.) and have also been described elsewhere . The isolation and characterization of MAb C2E9 together with other MAbs isolated in Newcastle will be the subject of a separate communication. (MAb C2E9 is the only one which does not neutralize the Beaudette C strain of NDV.)
The results in Fig. 1 (a) show that each of the nine MAbs bound to the HN protein of the Beaudette C strain (wild-type) of NDV even when virions had been boiled for 2 min in the presence of 1% SDS. However, when virions were boiled for 2 min in the presence of * MAbs 2B6 and 8E8 gave considerably weaker reactions than other MAbs (see Fig. la ).
-I-, Positive reaction; -, no reaction; +/-, weak positive reaction. :~ Mutants are denoted by the MAb to which they are resistant.
2-mercaptoethanol as reducing agent with 1 ~ SDS then only MAbs 14, AC3, JB6, 4D6 and C2E9 continued to detect any HN antigen (Fig. I b) . These data are consistent with the finding of Le for Western blotting against the Italien strain of NDV using MAbs AC3, JB6 and 4D6 and that of Samson (1986) for MAb 14 against Beaudette C. MAb C2E9 although reacting strongly against the HN protein also reacted non-specifically with other proteins present in purified ND virions. MAbs that continue to react with reduced HN protein are likely to recognize linear rather than conformational epitopes within HN.
Neutralizing MAbs 8C11, 4D6, AC3 and JB6 were initially used to select antibody-resistant mutants of the Beaudette C strain of NDV. The procedure involved plating dilutions of plaquepurified wild-type virus and overlaying with HEPES-buffered Medium 199 containing 5 ~o calf serum and 1 ~o agar to which was added unheated ascites fluid at 1/500 or 1/1000 dilution as previously described (Samson et al., 1985) . Wild-type plaque-purified antibody-resistant mutants were grown in ovo; chorioallantoic fluid was collected, clarified by centrifugation at 3000 g for 5 min and prepared for SDS-PAGE and Western blotting as previously described (Samson, 1986) . No further purification was necessary for cross-reactivity blotting tests (Table  1) , however wild-type virions were purified on sucrose/potassium tartrate density gradients (Chambers & Samson, 1980) prior to testing the sensitivity of HN protein to 2-mercaptoethanol as reducing agent (Fig. 1) , for the preparation of protease digest fragments of virus proteins (Fig.  2) and for the chemical cleavage of virus proteins (Fig. 4) .
Spontaneous mutants resistant to 8Cll, 4D6, AC3 and JB6 were isolated and clarified chorioallantoic fluid from infected eggs was used directly for SDS-PAGE and Western blotting to determine the cross-reactivity pattern of these mutants to these and other MAbs rapidly. This procedure is quicker and easier to perform than cross-neutralization tests though the latter have been conducted using these mutants and fully corroborate the blotting studies (not shown). Table 1 shows the results of the cross-reactivity blot test between the various mutants and the nine MAbs. As expected, all MAb-resistant mutants failed to bind the respective selecting antibody. Furthermore all 4D6-, AC3-and JB6-resistant mutants also failed to bind any of the following MAbs: 14, JB6, 2B6, 4D6, AC3 or 8E8. The 8Cl 1-resistant mutants failed to bind only (Laemmli, 1970) without reducing agent and dispensed into five tubes containing various amounts of S. aureus V8 protease, a sixth tube contained V8 protease but no virus. The tubes were incubated at 37 °C for 30 rain and frozen at -20 °C. Samples were boiled again for 2 rain prior to loading onto 10~ SDS-polyacrylamide gels and detection of antigen binding as described for Fig. 1 The grouping of the nine MAbs was then examined using an independent criterion, the rationale for which is as follows. If two MAbs react with a common linear sequence (epitope), or indeed overlapping or closely linked sequences within a polypeptide, then if the polypeptide is digested with a variety of proteases to give a ladder of partial digests which are then Western blotted against MAbs, identical and often overlapping or closely linked epitopes should reveal similar peptide blotting fingerprints. Epitopes which are separated by protease cleavage should reveal different fingerprints. Fig. 2 shows the result of such an analysis using the SDS-tolerant protease V8 from Staphylococcus aureus. We have also successfully used diphenylcarbamyl chloride-treated trypsin and chymotrypsin to generate different digest patterns (not shown). The blotted gels are purposely overloaded to allow detection of minor cleavage bands and this accounts for the very broad undigested HN bands in certain wells. Two of the MAbs, 2B6 and 8E8, which bind comparatively weakly to HN protein detect no cleavage products of the HN protein; the binding sites recognized by these MAbs are also sensitive to reducing agent (Fig. 1) , These data suggest that the epitope(s) recognized by 2B6 and 8E8 is (are) complex and not merely sensitive to destruction of cysteine cysteine disulphide bridges but by any disruption of the integrity of the HN protein, such as that brought about by protease treatment. In contrast MAbs 8C11 and 445, which also only bind to unreduced HN protein, both react with partial digest products of HN and show the same partial digest fragment blotting patterns. This implies that the epitope(s) recognized by 8C 11 and 445 are made up of linked sequences probably held in juxtaposition by disulphide bridge(s). Apart from C2E9 which showed a very ill-defined complex pattern, the remaining MAbs (14, JB6, 4D6 and AC3) appeared to be related by their pattern of digest reactions. MAb 14 was extremely avid and showed a very clear and distinct pattern, JB6, 4D6 and AC3 were less avid and the digest fragments did not show up as well; however, examination of the original blots revealed several common partial digest bands among this group which are distinct from the other (445/8C 11 and C2E9) patterns. The above digest patterns taken together with the cross-reactivity data (Fig. 2 ) and sensitivity to reducing agent (Fig. 1) suggest the following groupings: group la, MAbs 14, 4D6, AC3 and JB6; group lb, MAbs 2B6, 8E8 (sensitive to reducing agent); group 2a, MAb 445 (sensitive to reducing agent); group 2b, MAb 8C11 (sensitive to reducing agent); group 3, MAb C2E9. and earlier made a similar distinction between MAb 14 (their group HN-1) and MAb 445 (their group HN-2) on the basis of competition binding, haemagglutination inhibition and strain variation. This distinction is fully supported by our findings.
In an attempt to determine the location of the group la epitope within the HN polypeptides (likely to be a linear epitope because of its resistance to boiling in SDS under reducing conditions), we decided to use a variety of chemical cleavage procedures which should cleave the HN protein at known positions (the HN gene sequence for this strain being known ; Millar et al., 1986) . The formic acid cleavage at aspartate-proline linkages (Piszkiewicz et al., 1970) proved the most successful. The published HN sequence predicts that there should be three aspartateproline sites at pr'oline amino acid positions 130, 386 and 473 within the 577 residue protein for the Beaudette C strain of NDV (see Fig. 3 ).
Within the four complete digest fragments (1 to 4, Fig. 3 ) predicted from the gene sequence there are respectively zero, seven, three and four cysteine residues which could be involved in disulphide linkages. Fragments 1, 2 and 3 each have one and fragment 4 has two potential (and conserved) glycosylation sites (Millar et al., 1986; Jorgensen et al., 1987 and N. S. Millar, personal communication) . Taking into consideration the predicted sizes of these four fragments and partial digest fragments, together with the Western blot pattern obtained following a twodimensional non-reduced/reduced SDS-PAGE separation of formic acid-cleaved purified virions, the following spot assignments could be made (compare Fig. 3 and 4) . (Piszkiewicz et al., 1970) . The suspension was dialysed overnight against Tris-saline buffer (25 mM-Tris HC1, 137 mM-NaCI, 0.7 mM-NazHPO4 pH 7-2) and boiled for 2 min in 1 ~ SDS sample buffer without reducing agent prior to separation by 10~ SDS-PAGE (Laemmli, 1970) . A vertical 0.5 cm wide strip of this first dimension gel was cut out and equilibrated for 30 min in sample buffer containing 2.5~ 2-mercaptoethanol prior to the second dimension separation also by 10~ SDS-PAGE. The gel was blotted onto nitrocellulose paper and antigen detected as in Fig. 1 using MAb 4D6. disulphide bridge(s) between fragments 2 and 3. In the second dimension the disulphides are reduced and cleaved fragments now fall below the diagonal. It must be remembered that in this Western blot analysis only polypeptides that contain the epitope-bearing fragment will be detected by the MAb. For Fig. 4 , MAb,4D6 was used and the same spot pattern was obtained with the remaining MAbs in group la, namely 14, AC3 and JB6 (not shown). The only common region for all spots that bound the group la MAbs was region 2 (Fig. 3) , i.e. amino acid residues 130 to 385, which we predict contains this linear epitope. The data also predict that region 2 is disulphide-linked to region 3 (residues 386 to 473).
The cross-reactivity blot tests alone using antibody-resistant mutants (Table 1) suggested that MAbs 14, JB6, 2B6, 4D6, AC3 and 8E8 recognized a common epitope or portion of an epitope. Further support for this has been obtained from a set of ten independent M A b 14-resistant mutants which all failed to bind MAbs 14, 2B6 and AC3 but continued to bind M A b 445 (other MAbs were not tested). The common region recognized by these MAbs was thought to be linear in the case of 14, JB6, 4D6 and AC3 but to involve another region(s) of the H N polypeptide for the binding of MAbs 2B6 and 8E8 which were both sensitive to reducing agent and to limited protease cleavage.
MAbs 8C11 and 445 on the other hand are in different groups to the above M A b s and on the basis of the cross-reactivity blot tests alone appear to be in two different groups. Their identical protease digest data however suggest that their epitopes are contained on a common polypeptide (see Fig. 2 ). Although so far none of our 8C11-resistant mutants failed to bind MAb 445, recently we found that approximately 50~o of our 445-resistant mutants failed to bind both MAb 445 and 8C11. Further support for grouping MAb 8C11 and 445 together comes from ELISAs which showed that individual MAbs from group 1 a or 1 b showed additive binding to HN antigen when mixed with individual MAbs from group 2a or 2b but that 445 (2a) was not additive against MAb 8Cll (2b) (not shown).
The non-reduced/reduced two-dimensional SDS-PAGE blot provided information concerning the location of the la linear epitope recognized by MAbs 14, JB6, 4D6 and AC3. The analysis predicted that the epitope was between residues 130 and 385. Recent cloning/expression work using synthetic oligonucleotides has now localized this epitope to within eight amino acid residues in the above region (P. Chambers et al., unpublished data) . Furthermore, preliminary RNA sequencing of a MAb 14-resistant mutant has shown a significant codon change within this eight amino acid region (K. Yusoffet al., unpublished data). Current work in this laboratory is aimed at pinpointing nucleotide base changes in a variety of antibody-resistant mutants in order to delineate neutralizing epitopes within NDV surface glycoproteins.
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